Status:
COMPLETED
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
Lead Sponsor:
Boston Medical Center
Conditions:
Methicillin-resistant Staphylococcus Aureus
Eligibility:
All Genders
Brief Summary
The prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) colonization and infections have been increasing in the general population, including the pediatric population. It has been reporte...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Infants born at \> 32 weeks of gestation.
- Mother must have been tested for MRSA prior to birth.
- Mother must be willing to provide informed consent for herself and infant.
- Mothers feel household contacts and caregivers will be willing to enroll in the study.
- Household contacts must be willing to provide informed consent (if greater than 18 years of age) or parent of household contact must be willing to provide informed consent for minors and the minor must provide assent (if greater than age 7) to enroll in study.
- Infant care givers must be willing to provide informed consent (if greater than 18 years of age) or parent of infant care giver must be willing to provide informed consent for minors and the minor must provide assent (if greater than age 7) to enroll in study.
- Exclusion criteria:
- Infants born at \< 32 weeks gestation.
- Infants who will not be receiving their primary care at Boston Medical Center.
- Household contact or Infant Care giver not willing to provide informed consent.
Exclusion
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01141101
Start Date
June 1 2010
End Date
June 1 2012
Last Update
May 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118